BR0200536A - Compostos de sulfonilpiridazinana úteis como inibidores de aldose reductase - Google Patents
Compostos de sulfonilpiridazinana úteis como inibidores de aldose reductaseInfo
- Publication number
- BR0200536A BR0200536A BR0200536-0A BR0200536A BR0200536A BR 0200536 A BR0200536 A BR 0200536A BR 0200536 A BR0200536 A BR 0200536A BR 0200536 A BR0200536 A BR 0200536A
- Authority
- BR
- Brazil
- Prior art keywords
- reductase inhibitors
- aldose reductase
- sulfonylpyridazinane
- compounds useful
- prodrug
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/18—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
"COMPOSTOS DE SULFONILPIRIDAZINANA úTEIS COMO INIBIDORES DE ALDOSE REDUCTASE". Esta invenção refere-se a novos compostos de sulfonilpiridazinana úteis como inibidores de aldose reductase no tratamento ou prevenção de certas complicações derivadas da diabetes mellitus, composições farmacêuticas compreendendo o sulfonilpiridazinana, composições farmacêuticas compreendendo uma combinação da sulfonilpiridazinana com um segundo agente farmacêutico, métodos terapêuticos compreendendo a administração de compostos de sulfonilpiridazinana, métodos terapêuticos compreendendo a administração dos compostos de sulfonilpiridazinana em combinação com um segundo agente farmacêutico e compostos úteis como intermediários para a preparação dos compostos de sulfonilpiridazinana desta invenção.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27225401P | 2001-02-28 | 2001-02-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0200536A true BR0200536A (pt) | 2003-04-29 |
Family
ID=23039045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0200536-0A BR0200536A (pt) | 2001-02-28 | 2002-02-27 | Compostos de sulfonilpiridazinana úteis como inibidores de aldose reductase |
Country Status (9)
Country | Link |
---|---|
US (1) | US6730674B2 (pt) |
EP (1) | EP1236720B1 (pt) |
JP (1) | JP2003128657A (pt) |
AT (1) | ATE297902T1 (pt) |
BR (1) | BR0200536A (pt) |
CA (1) | CA2373395C (pt) |
DE (1) | DE60204611T2 (pt) |
ES (1) | ES2240657T3 (pt) |
MX (1) | MXPA02002252A (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998003167A1 (en) | 1996-07-24 | 1998-01-29 | Warner-Lambert Company | Isobutylgaba and its derivatives for the treatment of pain |
EP1392310A1 (en) * | 2001-04-30 | 2004-03-03 | Pfizer Products Inc. | Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors |
AU761191B2 (en) * | 2001-05-24 | 2003-05-29 | Pfizer Products Inc. | Therapies for tissue damage resulting from ischemia |
KR20030061051A (ko) * | 2002-01-07 | 2003-07-18 | 대한민국 (경상대학교 총장) | 신규한 아렌(혹은 알케인)술폰일피리다진온 유도체, 이의제조방법 및 유기반응에서의 용도 |
DE602005025755D1 (de) * | 2004-06-04 | 2011-02-17 | Teva Pharma | Irbesartan enthaltende pharmazeutische zusammensetzung |
CA2614529C (en) * | 2005-07-21 | 2011-06-28 | F. Hoffmann-La Roche Ag | Pyridazinone derivatives as thyroid hormone receptor agonists |
SG157299A1 (en) | 2008-05-09 | 2009-12-29 | Agency Science Tech & Res | Diagnosis and treatment of kawasaki disease |
GB0907601D0 (en) * | 2009-05-01 | 2009-06-10 | Equateq Ltd | Novel methods |
WO2017168174A1 (en) | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | New pharmaceutical forms of sildenafil |
WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE574204A (fr) * | 1958-12-24 | 1959-06-24 | Henri Morren | Dérives de sulfonyl-pyridazine |
IE47592B1 (en) | 1977-12-29 | 1984-05-02 | Ici Ltd | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture |
US4939140A (en) | 1985-11-07 | 1990-07-03 | Pfizer Inc. | Heterocyclic oxophthalazinyl acetic acids |
US4996204A (en) | 1989-05-11 | 1991-02-26 | Pfizer Inc. | Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors |
FR2647676A1 (fr) | 1989-06-05 | 1990-12-07 | Union Pharma Scient Appl | Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase |
EP0582643A1 (en) * | 1991-03-28 | 1994-02-16 | Pfizer Inc. | Pyridazinone acetic acids |
TWI238064B (en) | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
EP1491540B1 (en) * | 2001-03-30 | 2006-12-13 | Pfizer Products Inc. | Intermediates useful for the synthesis of pyridazinone aldose reductase inhibitors |
AU761191B2 (en) * | 2001-05-24 | 2003-05-29 | Pfizer Products Inc. | Therapies for tissue damage resulting from ischemia |
-
2002
- 2002-02-20 AT AT02251173T patent/ATE297902T1/de not_active IP Right Cessation
- 2002-02-20 DE DE60204611T patent/DE60204611T2/de not_active Expired - Fee Related
- 2002-02-20 EP EP02251173A patent/EP1236720B1/en not_active Expired - Lifetime
- 2002-02-20 ES ES02251173T patent/ES2240657T3/es not_active Expired - Lifetime
- 2002-02-26 US US10/085,609 patent/US6730674B2/en not_active Expired - Fee Related
- 2002-02-26 CA CA002373395A patent/CA2373395C/en not_active Expired - Fee Related
- 2002-02-27 JP JP2002050684A patent/JP2003128657A/ja not_active Withdrawn
- 2002-02-27 MX MXPA02002252A patent/MXPA02002252A/es unknown
- 2002-02-27 BR BR0200536-0A patent/BR0200536A/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE297902T1 (de) | 2005-07-15 |
US6730674B2 (en) | 2004-05-04 |
US20030004139A1 (en) | 2003-01-02 |
CA2373395A1 (en) | 2002-08-28 |
DE60204611D1 (de) | 2005-07-21 |
CA2373395C (en) | 2006-01-10 |
EP1236720B1 (en) | 2005-06-15 |
EP1236720A1 (en) | 2002-09-04 |
JP2003128657A (ja) | 2003-05-08 |
ES2240657T3 (es) | 2005-10-16 |
MXPA02002252A (es) | 2002-09-30 |
DE60204611T2 (de) | 2006-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200309887B (en) | Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents. | |
NO20062644L (no) | DPP-IV inhibitorer | |
WO2006005609A3 (de) | Substituierte oxindol-derivate und diese enthaltende arzneimittel | |
NO20035327D0 (no) | Biologisk aktive metylen-blått derivater | |
DK1487444T3 (da) | Anvendelse af pyridylamider som angiogeneseinhibitorer | |
CY1106958T1 (el) | Ν-αλκυλο-4-μεθυλεναμινο-3-υδροξυ-2-πυριδονες ως αντιμικροβιακα | |
IL189694A0 (en) | Biphenyl derivatives and their use in treating hepatitis c | |
EP1764092A3 (en) | Selecting compounds for treatment of Alzheimer's disease | |
WO2006047528A3 (en) | Pyrazolobenzamides and derivatives as factor xa inhibitors | |
WO2005021497A3 (en) | Tethered dimers and trimers of 1,4-diphenylazetidn-2-ones | |
EP1371640A4 (en) | NEW A-LIPONIC ACID DERIVATIVE AND ITS USE | |
IL169184A0 (en) | Aromatic compounds as anti-inflammatory, immunomdulatory and anti-proliferatory agents | |
PE20030061A1 (es) | 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4 | |
MXPA04006041A (es) | Antivirales de piridoquinoxalina. | |
BR0200536A (pt) | Compostos de sulfonilpiridazinana úteis como inibidores de aldose reductase | |
MX2008001778A (es) | Combinacion de un agente hipnotico y un compuesto de bis arilo y heteroarilo sustituido y aplicacion terapeutica de la misma. | |
IL190024A0 (en) | Stabilized protease composition | |
WO2004043928A8 (en) | N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents | |
UA83266C2 (en) | Oxazole derivatives of tetracyclines | |
NO20053997D0 (no) | Oligosaccharidderivat | |
PT1072601E (pt) | Derivados de 4-arilpiperidina para o tratamento de prurido | |
ATE334977T1 (de) | Discodermolid-analoga und ihre pharmazeutische verwendung | |
ATE338046T1 (de) | 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza- cyclopenta(a)naphthalenyl derivate mit antipsychotischer aktivität | |
HK1122798A1 (en) | 1- [2' , 3' -dideoxy-3' c- (hydroxymethyl) - beta-d-erythro-pentofuranosyl] cytosine derivatives as hiv inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1980 DE 16/12/2008. |